Author

D. Murugan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:Arabidopsis· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Veeraraghavan· 2 shared D. P. Muthuirulandi Sethuvel· 2 shared G. P. D. C· 2 shared N. K. Devanga Ragupathi· 2 shared A. W. Lund· 1 shared C. Hill· 1 shared E. Karunakaran· 1 shared H. du Bois· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. Veeraraghavan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

T cell Egress via Lymphatic Vessels Limits the Intratumoral T cell Repertoire in Melanoma

M. M. Steele, I. D. Dryg, D. Murugan, J. Femel, H. du Bois, C. Hill, S. A. Leachman, Y. H. Chang, L. M. Coussens, A. W. Lund

The paper shows that T cell egress via lymphatic vessels limits intratumoral T cell diversity, and that CXCR4 inhibition enhances T cell retention and improves immunotherapy response.

bioRxiv · May 30, 2022 · PreprintImmunology

Re-sensitising XDR biofilms using a combination of bacteriophage cocktails and colistin: a natural approach

N. K. Devanga Ragupathi, D. P. Muthuirulandi Sethuvel, M. Gopikrishnan, D. Murugan, R. Juliet, M. Majhi, M. Murugesan, G. P. D. C, L. Wannigama, P. N. Monk, E. Karunakaran, B. Veeraraghavan

This study explores using bacteriophage cocktails combined with colistin to combat XDR bacterial biofilms, showing significant reduction in minimum biofilm eradication concentrations.

bioRxiv · Feb 4, 2022 · PreprintMicrobiology

First hybrid complete genome of Aeromonas veronii reveals chromosome-mediated novel structural variant mcr-3.19 from human clinical specimen

N. K. Devanga Ragupathi, D. P. Muthuirulandi Sethuvel, S. Anandan, D. Murugan, K. Asokan, R. G. Neethi Mohan, K. Vasudevan, T. K. D, G. P. D. C, B. Veeraraghavan

The paper identifies a novel mcr-3 variant (mcr-3.19) in a colistin-susceptible Aeromonas veronii isolate using hybrid genome assembly and confirms its structural and functional characteristics.

bioRxiv · Mar 14, 2019Microbiology